Have you checked your patients' inflammation levels?
Research data strongly support a crucial role played by inflammatory and immune mechanisms in cardiovascular disease. #inflammation https://t.co/N5N67zJILh
Changes in inflammatory marker levels, seen only with technology available through Veridia, predict improvements in disease.
In this study a reduction in SMC IL-17A was required for psoriasis disease remission regardless of therapeutic agent. #inflammation
https://t.co/Q4Y4xco1z5
Study Shows Improvement in Biomarkers Offered Through Veridia!
A defined, plant‐based diet utilized in an outpatient cardiovascular clinic effectively treats hypercholesterolemia and hypertension and reduces medications. @DrBMontgomery @clincardiology https://t.co/3FmsxkCkCS
Study adds to understanding about utility of ultra-sensitive cardiac troponin measurement in diagnosing and predicting cardiovascular syndromes. @JAHA_AHA https://t.co/sUpjBxk85Z
Reference Ranges for our SMC cTnI have been published @Clin_Chem_AACC .
Comprehensive Age and Sex 99th Percentiles for a High-Sensitivity Cardiac Troponin I Assay https://t.co/cZ4IS0wKkg
Most standard blood tests detect elevated disease markers once the patient is already ill. Learn how Veridia helps detect disease earlier. https://t.co/Wyv5DK472p
Only measuring cholesterol won't tell you the whole picture on heart health - 50% of patients with first time ER admissions for a heart attack have “normal” cholesterol levels. Veridia blood tests can help give you a more complete picture. https://t.co/9Z7ojjcGHX
Can a blood test tell you if you're at higher risk of cardiac death without having symptoms? Our proprietary biomarker, SMC troponin I, can help evaluate this risk. https://t.co/rCtBUGqE5j
It’s American #HeartMonth – officially the perfect time to check in on your heart health. Here are 7 ways to improve your cardiovascular health: https://t.co/LuDpxVTznH #AHANews https://t.co/yjCgf8Oowl